| 17th Jul 2013 7:00 am |
RNS |
Global Phase III HPML-004 maintenance study starts |
| 1st Jul 2013 7:00 am |
RNS |
Blocklisting Interim Review |
| 25th Jun 2013 7:00 am |
RNS |
Volitinib Phase I triggers US$5 million milestone |
| 24th Jun 2013 7:00 am |
RNS |
Notice of Results |
| 10th May 2013 12:24 pm |
RNS |
Result of AGM |
| 24th Apr 2013 7:00 am |
RNS |
Global Phase III UC trial initiated with HPML-004 |
| 12th Apr 2013 7:16 am |
RNS |
Nutrition Science Partners JV Approved |
| 9th Apr 2013 7:00 am |
RNS |
2012 Annual Report and Notice of AGM |
| 8th Apr 2013 7:00 am |
RNS |
Data Presentations at AACR |
| 26th Mar 2013 7:00 am |
RNS |
Final Results |
| 28th Feb 2013 7:00 am |
RNS |
Total Voting Rights |
| 18th Feb 2013 7:00 am |
RNS |
Notice of Results |
| 28th Jan 2013 11:15 am |
RNS |
Holding(s) in Company |
| 31st Dec 2012 7:00 am |
RNS |
Blocklisting Six Monthly Return |
| 28th Nov 2012 7:00 am |
RNS |
Chi-Med and Nestle´ Health Science Joint Venture |
| 1st Nov 2012 7:00 am |
RNS |
Phase I trial with EGFR inhibitor theliatinib |
| 8th Oct 2012 7:00 am |
RNS |
TR1 Notification of major interest in shares |
| 28th Sep 2012 1:42 pm |
RNS |
Total Voting Rights |
| 13th Sep 2012 2:16 pm |
RNS |
Director's Shareholding |
| 28th Aug 2012 11:21 am |
RNS |
Change of Nominated Adviser |
| 31st Jul 2012 7:00 am |
RNS |
Interim Results |
| 5th Jul 2012 9:08 am |
RNS |
Total Voting Rights |
| 29th Jun 2012 7:00 am |
RNS |
Blocklisting Interim Review |
| 28th Jun 2012 7:00 am |
RNS |
Notice of Results |
| 14th Jun 2012 1:33 pm |
RNS |
Exercise of Options |
| 6th Jun 2012 7:00 am |
RNS |
Anti-Cancer Clinical Data Presented at ASCO |
| 30th May 2012 1:48 pm |
RNS |
Director/PDMR Shareholding |
| 11th May 2012 12:32 pm |
RNS |
Result of AGM |
| 10th Apr 2012 7:00 am |
RNS |
2011 Annual Report and Notice of AGM |
| 20th Mar 2012 7:00 am |
RNS |
Final Results |
| 22nd Feb 2012 7:00 am |
RNS |
Novel c-Met inhibitor Volitinib Enters the Clinic |
| 20th Feb 2012 7:00 am |
RNS |
Notice of Results |
| 14th Feb 2012 8:07 am |
RNS |
Holding(s) in Company |
| 2nd Feb 2012 7:00 am |
RNS |
Total Voting Rights |
| 5th Jan 2012 10:49 am |
RNS |
Holding(s) in Company |
| 29th Dec 2011 7:00 am |
RNS |
Blocklisting Six Monthly Return |
| 21st Dec 2011 7:00 am |
RNS |
CANCER THERAPY COLLABORATION WITH ASTRAZENECA |
| 12th Dec 2011 7:00 am |
RNS |
Chi-Med Loan Facility |
| 4th Nov 2011 7:00 am |
RNS |
Initiates Epitinib Phase I clinical study |
| 5th Sep 2011 7:00 am |
RNS |
Holding(s) in Company |
